Farallon Capital Management LLC Capricor Therapeutics, Inc. Transaction History
Farallon Capital Management LLC
- $17.4 Billion
- Q1 2025
A detailed history of Farallon Capital Management LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,250,400 shares of CAPR stock, worth $25.5 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,250,400Holding current value
$25.5 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
17.2MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$25.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$18.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$10.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY815KShares$9.25 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $276M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...